Cancer immunotherapy with immune checkpoint inhibitors-biomarkers of response and toxicity; current limitations and future promise
Immune checkpoint inhibitors are monoclonal antibodies that are used to treat over one in
three cancer patients. While they have changed the natural history of disease, prolonging …
three cancer patients. While they have changed the natural history of disease, prolonging …
[HTML][HTML] 14 色流式检测人外周血白细胞亚群方案的建立
巧容黄， 燕妮蒋， 慧芳李， 雪李… - Journal of Sichuan …, 2022 - ncbi.nlm.nih.gov
目的建立14 色流式检测人外周血中白细胞亚群方案. 方法用细胞膜表面抗体CD45, CD3, CD4,
CD8, CD19, CD56, CD16, CD14, CD25, CD127, HLA-DR, CD123, CD11c 和核酸染料DAPI …
CD8, CD19, CD56, CD16, CD14, CD25, CD127, HLA-DR, CD123, CD11c 和核酸染料DAPI …
[HTML][HTML] 21 色流式检测人非小细胞肺癌组织中免疫细胞亚群方案的建立
GUO Tingting, XIE Hongguan - Chinese Journal of Lung Cancer, 2024 - ncbi.nlm.nih.gov
背景与目的肺癌组织的免疫微环境已成为关注的重点， 随着多色流式的兴起，
流式检测肺癌免疫微环境成为重要的手段， 但多为检测细胞亚群占比或主要细胞亚群功能 …
流式检测肺癌免疫微环境成为重要的手段， 但多为检测细胞亚群占比或主要细胞亚群功能 …
Establishment of a 21-color Panel for the Detection of Immune Cell Subsets in Human Non-small Cell Lung Cancer Tumor Tissues with Flow Cytometry.
GUO Tingting, XIE Hongguan - Chinese Journal of Lung …, 2024 - search.ebscohost.com
Background and objective With the rise of multicolor flow cytometry, flow cytometry has
become an important means to detect the immune microenvironment of lung cancer, but …
become an important means to detect the immune microenvironment of lung cancer, but …
[HTML][HTML] West Ashley Library
T Guo, H Xie - Zhongguo fei ai za zhi= Chinese journal of lung cancer …, 2024 - ccpl.org
Background: With the rise of multicolor flow cytometry, flow cytometry has become an
important means to detect the immune microenvironment of lung cancer, but most of them …
important means to detect the immune microenvironment of lung cancer, but most of them …
Cancer Immunotherapy Biomarkers of Response and Toxicity; current limitations and future promise
Abstract Immune Checkpoint Inhibitors are monoclonal antibodies that are used to treat over
one in three cancer patients. While they have changed the natural history of disease …
one in three cancer patients. While they have changed the natural history of disease …